• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗糖尿病合并症的减肥手术:聚焦于肝纤维化、心脏纤维化和肾纤维化。

Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis.

作者信息

Ding Huanxin, Zhang Yun, Ma Xiaomin, Zhang Zhongwen, Xu Qian, Liu Chuxuan, Li Bingjun, Dong Shuohui, Li Linchuan, Zhu Jiankang, Zhong Mingwei, Zhang Guangyong

机构信息

Department of General Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China.

Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.

出版信息

Front Pharmacol. 2022 Oct 21;13:1016635. doi: 10.3389/fphar.2022.1016635. eCollection 2022.

DOI:10.3389/fphar.2022.1016635
PMID:36339532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9634081/
Abstract

Continuously rising trends in diabetes render this disease spectrum an epidemic proportion worldwide. As the disease progresses, the pathological effects of diabetes may impair the normal function of several vital organs, eventually leading to increase the risk of other diabetic comorbidities with advanced fibrosis such as non-alcoholic fatty liver disease, diabetic cardiomyopathy, and diabetic kidney disease. Currently, lifestyle changes and drug therapies of hypoglycemic and lipid-lowering are effective in improving multi-organ function, but therapeutic efficacy is difficult to maintain due to poor compliance and drug reactions. Bariatric surgery, including sleeve gastrectomy and Roux-en-Y gastric bypass surgery, has shown better results in terms of prognosis for diabetes through long-term follow-up. Moreover, bariatric surgery has significant long-term benefits on the function of the heart, liver, kidneys, and other organs through mechanisms associated with reversal of tissue fibrosis. The aim of this review is to describe the impact of type 2 diabetes mellitus on hepatic, cardiac and renal fibrosis and to summarize the potential mechanisms by which bariatric surgery improves multiple organ function, particularly reversal of fibrosis.

摘要

糖尿病的持续上升趋势使这种疾病在全球范围内呈现出流行态势。随着疾病的进展,糖尿病的病理影响可能会损害多个重要器官的正常功能,最终导致其他伴有晚期纤维化的糖尿病合并症风险增加,如非酒精性脂肪性肝病、糖尿病心肌病和糖尿病肾病。目前,生活方式的改变以及降糖和降脂药物治疗在改善多器官功能方面是有效的,但由于依从性差和药物反应,治疗效果难以维持。包括袖状胃切除术和Roux-en-Y胃旁路手术在内的减重手术,通过长期随访显示出在糖尿病预后方面有更好的效果。此外,减重手术通过与组织纤维化逆转相关的机制,对心脏、肝脏、肾脏和其他器官的功能具有显著的长期益处。本综述的目的是描述2型糖尿病对肝、心和肾纤维化的影响,并总结减重手术改善多器官功能,特别是逆转纤维化的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/9634081/698636fcf4c2/FPHAR_fphar-2022-1016635_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/9634081/698636fcf4c2/FPHAR_fphar-2022-1016635_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/9634081/698636fcf4c2/FPHAR_fphar-2022-1016635_wc_abs.jpg

相似文献

1
Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis.用于治疗糖尿病合并症的减肥手术:聚焦于肝纤维化、心脏纤维化和肾纤维化。
Front Pharmacol. 2022 Oct 21;13:1016635. doi: 10.3389/fphar.2022.1016635. eCollection 2022.
2
ACCURACY OF ELASTOGRAPHY IN THE ASSESSMENT OF REDUCTION IN LIVER STEATOSIS AND FIBROSIS IN THE EARLY POSTOPERATIVE PERIOD AFTER BARIATRIC SURGERY.弹性成像在评估减重手术后早期肝脂肪变性和纤维化减轻中的准确性。
Arq Bras Cir Dig. 2022 Aug 26;35:e1671. doi: 10.1590/0102-672020220002e1671. eCollection 2022.
3
Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.肥胖症糖尿病患者与非糖尿病患者行减重手术后对肝脏葡萄糖代谢的影响。
J Hepatol. 2014 Feb;60(2):377-83. doi: 10.1016/j.jhep.2013.09.012. Epub 2013 Sep 20.
4
Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.腹腔镜袖状胃切除术与 Roux-en-Y 胃旁路术治疗肥胖症的疗效比较:基于 18 项研究的系统评价和荟萃分析
Int J Surg. 2020 Apr;76:101-110. doi: 10.1016/j.ijsu.2020.02.035. Epub 2020 Mar 6.
5
Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy.肥胖症患者肾结石病史的胃旁路手术与袖状胃切除术:24 小时尿液分析和影像学改变。
Obes Surg. 2021 Apr;31(4):1673-1679. doi: 10.1007/s11695-020-05178-9. Epub 2021 Jan 2.
6
Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass.腹腔镜袖状胃切除术和 Roux-en-Y 胃旁路术后血清代谢组学的短期变化。
Metabolomics. 2021 Aug 5;17(8):71. doi: 10.1007/s11306-021-01826-y.
7
Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.袖状胃切除术和 Roux-en-Y 胃旁路术对活检证实的非酒精性脂肪性肝病的影响。
Surg Endosc. 2020 May;34(5):2266-2272. doi: 10.1007/s00464-019-07017-0. Epub 2019 Jul 29.
8
Bariatric Surgery With Roux-En-Y Gastric Bypass or Sleeve Gastrectomy for Treatment of Obesity and Comorbidities: Current Evidence and Practice.采用Roux-en-Y胃旁路术或袖状胃切除术的减重手术治疗肥胖症及合并症:当前证据与实践
Cureus. 2022 Jun 8;14(6):e25762. doi: 10.7759/cureus.25762. eCollection 2022 Jun.
9
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.腹腔镜袖状胃切除术与腹腔镜Roux-en-Y胃旁路术对病态肥胖患者体重减轻的影响:SM-BOSS随机临床试验
JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897.
10
Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.60岁以上患者行腹腔镜袖状胃切除术和Roux-en-Y胃旁路术的疗效
Obes Surg. 2015 Dec;25(12):2251-6. doi: 10.1007/s11695-015-1712-9.

引用本文的文献

1
Clinical outcomes of roux-en-Y gastric bypass versus medical therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.Roux-en-Y胃旁路术与药物治疗2型糖尿病的临床结局:一项系统评价和荟萃分析
J Diabetes Metab Disord. 2025 Jan 10;24(1):43. doi: 10.1007/s40200-024-01526-z. eCollection 2025 Jun.
2
Abdominal obesity is associated with increased worsening renal function risk in patients with heart failure with preserved ejection fraction.腹型肥胖与射血分数保留的心力衰竭患者肾功能恶化风险增加相关。
BMC Cardiovasc Disord. 2024 Sep 9;24(1):477. doi: 10.1186/s12872-024-04118-0.
3
Role of bariatric surgery in improving diabetic cardiomyopathy: Molecular mechanisms and therapeutic perspectives (Review).

本文引用的文献

1
Sleeve Gastrectomy-Induced AMPK Activation Attenuates Diabetic Cardiomyopathy by Maintaining Mitochondrial Homeostasis NR4A1 Suppression in Rats.袖状胃切除术诱导的AMPK激活通过维持线粒体稳态减轻大鼠糖尿病心肌病中的NR4A1抑制。
Front Physiol. 2022 Mar 10;13:837798. doi: 10.3389/fphys.2022.837798. eCollection 2022.
2
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis.抑制肝星状细胞中的肉碱棕榈酰转移酶1A可预防肝纤维化。
J Hepatol. 2022 Jul;77(1):15-28. doi: 10.1016/j.jhep.2022.02.003. Epub 2022 Feb 12.
3
Bariatric Surgery Induces a Differential Effect on Plasma Aldosterone in Comparison to Dietary Advice Alone.
减重手术改善糖尿病性心肌病的作用:分子机制和治疗观点(综述)。
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13323. Epub 2024 Sep 6.
4
Diabetic Cardiomyopathy-From Basics through Diagnosis to Treatment.糖尿病性心肌病——从基础到诊断再到治疗
Biomedicines. 2024 Mar 29;12(4):765. doi: 10.3390/biomedicines12040765.
5
The impact of weight loss on renal function in individuals with obesity and type 2 diabetes: a comprehensive review.减肥对肥胖合并 2 型糖尿病患者肾功能的影响:综合评价。
Front Endocrinol (Lausanne). 2024 Jan 31;15:1320627. doi: 10.3389/fendo.2024.1320627. eCollection 2024.
6
Adipose tissue fibrosis: the unwanted houseguest invited by obesity.脂肪组织纤维化:肥胖邀请的不速之客。
J Endocrinol. 2023 Oct 19;259(3). doi: 10.1530/JOE-23-0180. Print 2023 Dec 1.
7
Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments.探讨线粒体在糖尿病心肌病中的作用的新见解:分子机制和潜在治疗方法。
Cell Stress Chaperones. 2023 Nov;28(6):641-655. doi: 10.1007/s12192-023-01361-w. Epub 2023 Jul 5.
减重手术与单纯饮食建议相比对血浆醛固酮产生不同的影响。
Front Endocrinol (Lausanne). 2021 Oct 5;12:745045. doi: 10.3389/fendo.2021.745045. eCollection 2021.
4
Deletion of Smad3 protects against C-reactive protein-induced renal fibrosis and inflammation in obstructive nephropathy.Smad3 缺失可防止 C-反应蛋白诱导的梗阻性肾病中的肾纤维化和炎症。
Int J Biol Sci. 2021 Sep 21;17(14):3911-3922. doi: 10.7150/ijbs.62929. eCollection 2021.
5
Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects.Toll 样受体 4 和髓样分化因子 88 是胃旁路术引起代谢效应所必需的。
Surg Obes Relat Dis. 2021 Dec;17(12):1996-2006. doi: 10.1016/j.soard.2021.07.019. Epub 2021 Aug 2.
6
Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity.肥胖症患者的脂肪组织巨噬细胞群和炎症与全身炎症和胰岛素抵抗有关。
Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E105-E121. doi: 10.1152/ajpendo.00070.2021. Epub 2021 May 17.
7
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
8
Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.胃旁路手术与袖状胃切除术治疗非酒精性脂肪性肝病的比较:系统评价和荟萃分析。
Obes Surg. 2021 Jun;31(6):2762-2772. doi: 10.1007/s11695-021-05412-y. Epub 2021 Apr 13.
9
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies.心肌纤维化:肌成纤维细胞介导的病理调节和药物传递策略。
Adv Drug Deliv Rev. 2021 Jun;173:504-519. doi: 10.1016/j.addr.2021.03.021. Epub 2021 Apr 5.
10
Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice.依泽替米贝通过激动法尼醇 X 受体改善小鼠非酒精性脂肪性肝炎和肝纤维化。
Phytother Res. 2021 Jun;35(6):3351-3364. doi: 10.1002/ptr.7055. Epub 2021 Mar 30.